Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Evotec SE

Start price
Target price
Perf. (%)
€13.99
23.02.24
€15.00
23.02.25
4.93%
29.03.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Well known brand
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.80
23.02.24
€0.000
23.02.25
-41.03%
12.05.24

Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.80
23.02.24
€0.000
23.02.25
-41.03%
12.05.24

buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.89
23.02.24
-
23.02.25
-14.29%
04.03.24

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€24.88
23.02.24
-
23.03.24
0.44%
23.03.24

Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.29
22.02.24
-
22.02.25
-17.66%
02.03.24

Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.55
22.02.24
-
22.02.25
4.52%
02.03.24

Very low/no dividend yield expected
Risky Investment
EBIT decline/stagnation expected
High valuation
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.19
22.02.24
-
22.02.25
-10.80%
02.03.24

Nicheplayer
Risky Investment
Bayer AG

Start price
Target price
Perf. (%)
€28.75
21.02.24
-
21.03.24
-6.87%
11.03.24

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Bayer AG

Start price
Target price
Perf. (%)
€28.75
21.02.24
-
21.03.24
-6.87%
11.03.24

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€11.40
21.02.24
€1.00
21.02.25
-42.98%
12.05.24

buy
Carl Zeiss Meditec AG

Start price
Target price
Perf. (%)
€112.00
20.02.24
€115.00
20.02.25
3.93%
04.03.24

buy
Carl Zeiss Meditec AG

Start price
Target price
Perf. (%)
€112.00
20.02.24
€115.00
20.02.25
3.93%
04.03.24

buy
Heron Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.78
19.02.24
€10.00
19.02.25
-20.43%
02.05.24

Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€7.79
19.02.24
-
19.02.25
-68.43%
27.02.24

Risky Investment
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€7.79
19.02.24
€6.00
16.05.26
-69.17%
03.03.24

Could be very worthwhile Investment >20% year
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.45
19.02.24
€0.000
19.02.25
-63.24%
12.05.24

buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.45
19.02.24
€12.00
19.02.25
-36.76%
06.03.24

Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.40
19.02.24
-
19.02.25
-25.85%
01.03.24

Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
-
19.02.25
-24.30%
02.03.24

buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€8.30
19.02.24
-
19.02.25
2.41%
03.03.24

Could be worthwhile Investment >10% per year
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
-
19.02.25
-24.30%
03.03.24

Probably not worthwhile Investment
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
€6.00
31.07.27
-44.67%
26.05.24

Could be very worthwhile Investment >20% year
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.40
19.02.24
-
19.02.25
-24.14%
04.03.24

Risky Investment
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€6.44
18.02.24
-
18.02.25
-14.29%
01.03.24